BIOMAT Database Logo BIOMAT Database Logo

Susceptibility of enterococci. II. Inhibitory and bactericidal activity of drugs in combination against Streptococcus faecalis and Streptococcus faecium. 1986

A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero

The microbiological utility of antibiotic combinations against Streptococcus faecalis and Streptococcus faecium strains was studied. The drugs used were netilmicin + amoxicillin (20 strains); netilmicin + piperacillin (20 strains); netilmicin- + vancomycin (20 strains); netilmicin + rifampicin (20 strains). Netilmicin used in combination with the penicillins was advantageous against Streptococcus faecalis, but not uniformly against Streptococcus faecium. The combinations of netilmicin with vancomycin or rifampicin were no more effective than the single drugs in most cases, although the response varied for the different strains of the two species.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis

Related Publications

A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Bactericidal activity of five combinations of penicillin G with aminoglycosides against Streptococcus faecium.
October 1984, European heart journal,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
May 1997, The Journal of antimicrobial chemotherapy,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
May 1987, Journal of clinical microbiology,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
[Enterococci, D-streptococci and streptococcus faecalis].
January 1952, Schweizerische Zeitschrift fur Pathologie und Bakteriologie. Revue suisse de pathologie et de bacteriologie,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Bactericidal activity of antibiotics alone and in combination against Enterococcus faecalis in a pharmacodynamic model.
September 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Bactericidal activity of ramoplanin against antibiotic-resistant enterococci.
October 1992, Antimicrobial agents and chemotherapy,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
A Novel Antimicrobial-Phytochemical Conjugate With Antimicrobial Activity Against Streptococcus uberis, Enterococcus faecium, and Enterococcus faecalis.
January 2019, Frontiers in pharmacology,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
[Typing of Streptococcus faecalis and Streptococcus faecium strains with bacteriophages].
October 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
Potential role of lysozyme in bactericidal activity of in vitro-acquired salivary pellicle against Streptococcus faecium 9790.
December 1986, Infection and immunity,
A Fabbri, and G Manno, and A Tacchella, and M L Belli, and C Palmero
THE DIFFERENTIATION OF STREPTOCOCCUS FAECALIS AND S. FAECIUM.
February 1965, Journal of general microbiology,
Copied contents to your clipboard!